Director/PDMR Shareholding

RNS Number : 7768Q

Allergy Therapeutics PLC

09 November 2012

 



9 November 2012

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

Director/PDMR Shareholding

Allergy Therapeutics plc (AIM: AGY), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, was informed on 8 November 2012 that Mr Ian Postlethwaite, a director, sold 493,000 Ordinary Shares of 0.1p each ("Ordinary Shares") on 8 November 2012 at a price of 12.75p per Ordinary Share.  Mr Postlethwaite intends to apply the proceeds of the sale towards the cost of exercising options in the Company in due course.

Following this disposal, Mr Ian Postlethwaite holds no Ordinary Shares and holds options and LTIPs representing 2,983,500 Ordinary Shares.

For further information

Allergy Therapeutics	[phone]
Manuel Llobet, Chief Executive Officer
Ian Postlethwaite, Finance Director
www.allergytherapeutics.com
Nomura Code Securities	[phone]
Juliet Thompson / Clare Terlouw
FTI Consulting	[phone]
Simon Conway / Susan Stuart / Victoria Foster-Mitchell

 

END

 

 

RDSBDBDBGBGBGDC